Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Healthy, Renal Impairment”

365 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 365 results

Early research (Phase 1)Study completedNCT02039817
What this trial is testing

PK and PD Study of IDN-6556 in Subjects With Severe Renal Impairment and Matched Healthy Volunteers

Who this might be right for
Renal ImpairmentRenal InsufficiencyKidney Disease+1 more
Conatus Pharmaceuticals Inc. 16
Early research (Phase 1)Study completedNCT02063204
What this trial is testing

To Assess the Pharmacokinetics, Safety and Tolerability of Selumetinib in Renal Impaired Subjects and Healthy Subjects

Who this might be right for
Solid Tumours
AstraZeneca 24
Early research (Phase 1)Study completedNCT05198778
What this trial is testing

A Safety, PK, PD and Food Effect Study of URC102 in Healthy Adults and Patients With Renal Impairment

Who this might be right for
Healthy, Renal Impairment
JW Pharmaceutical 28
Early research (Phase 1)Looking for participantsNCT07443059
What this trial is testing

Zovaglutide (ZT002 Injection) in Participants With Impaired Kidney Function and Healthy Participants

Who this might be right for
Overweight , Obesity
Beijing QL Biopharmaceutical Co.,Ltd 40
Early research (Phase 1)Study completedNCT02341599
What this trial is testing

Study of Pharmacokinetics of a Single IV Dose of CB-238,618 in Subjects With Varying Degrees of Renal Impairment Compared to Healthy Subjects (MK-6183-001)

Who this might be right for
Healthy VolunteersRenal Impairment
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 40
Not applicableLooking for participantsNCT07248371
What this trial is testing

Validating Integrative Multi-omics Approaches in Metabolic Syndrome-related Diseases

Who this might be right for
Metabolic Syndrome (MetS)Obesity & OverweightCardiovascular Diseases (CVD)+3 more
Chang Gung Memorial Hospital 6,266
Not applicableEnded earlyNCT00026702
What this trial is testing

Search for New Methods to Detect Acute Renal Failure

Who this might be right for
Kidney DiseaseKidney FailureKidney Failure, Chronic+2 more
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 226
Early research (Phase 1)Study completedNCT02547402
What this trial is testing

The PK Interaction of CXA-10 With Pravastatin and Vytorin® in Healthy Males

Who this might be right for
Acute Kidney Injury
Complexa, Inc. 10
Early research (Phase 1)Study completedNCT01266980
What this trial is testing

Assess the Effects of Repeat Doses of Fluticasone Furoate and GW642444M Combination in Healthy Subjects and in Subjects With Severe Impairment.

Who this might be right for
Pulmonary Disease, Chronic Obstructive
GlaxoSmithKline 18
Early research (Phase 1)Study completedNCT05404542
What this trial is testing

To Evaluate Pharmacokinetics (PK) and Safety of Tavapadon in Participants With Severe Renal Impairment Compared to Participants With Normal Renal Function

Who this might be right for
Renal Impairment
Cerevel Therapeutics, LLC 14
Early research (Phase 1)Study completedNCT05718648
What this trial is testing

Test How BI 1015550 is Taken up in the Blood of People With and Without Kidney Problems

Who this might be right for
Renal InsufficiencyHealthy
Boehringer Ingelheim 26
Not applicableStudy completedNCT00313430
What this trial is testing

Urinary Concentration and Diluting Ability in Patients With Chronic Renal Disease and/ or Hypertension

Who this might be right for
Renal Insufficiency, ChronicHypertension
Erling Bjerregaard Pedersen 50
Early research (Phase 1)Study completedNCT01316055
What this trial is testing

Pharmacokinetics (PK) of Dalfampridine-ER 7.5 mg BID in Healthy Volunteers and Subjects With Mild or Moderate Renal Impairment

Who this might be right for
Renal Insufficiency
Acorda Therapeutics 42
Early research (Phase 1)Study completedNCT02144285
What this trial is testing

LY3113593 in Healthy Participants and Participants With Chronic Kidney Disease Treated With Hemodialysis

Who this might be right for
Kidney Failure, Chronic
Eli Lilly and Company 64
Early research (Phase 1)Study completedNCT03976115
What this trial is testing

Evaluate the Safety and Efficacy of DDO-3055 in Healthy Volunteers and Patients With Chronic Kidney Disease

Who this might be right for
Chronic Kidney Disease
Jiangsu HengRui Medicine Co., Ltd. 54
Early research (Phase 1)Study completedNCT01369602
What this trial is testing

Study To Evaluate The Effect Of Renal Impairment On The Pharmacokinetics Of PF-04991532

Who this might be right for
Type 2 Diabetes MellitusHealthy
Pfizer 27
Very early researchLooking for participantsNCT07577817
What this trial is testing

Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of CTX001 in Healthy Adults.

Who this might be right for
AnemiaIron DeficienciesChronic Kidney Disease
Cajal Therapeutics Inc. 72
Early research (Phase 1)Study completedNCT00880750
What this trial is testing

Pharmacodynamic Study of Two Lanthanum Carbonate Formulations in Healthy Adults

Who this might be right for
End Stage Renal Disease
Shire 72
Early research (Phase 1)Study completedNCT01875523
What this trial is testing

PK of Serelaxin in Severe Renal Impairment and ESRD

Who this might be right for
Renal Failure, ChronicEnd-Stage Renal Disease
Novartis Pharmaceuticals 36
Early research (Phase 1)Study completedNCT04792333
What this trial is testing

Pharmacokinetics in End Stage Renal Disease Patients

Who this might be right for
Healthy VolunteersRenal Failure
Quantum Genomics SA 28
Next Page